FDA Inspection
American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc.American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc. – FDA Inspection, Jun 9, 2022
Record Details
This FDA Inspection record concerns American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc., with an inspection on June 9, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- June 9, 2022
- Product Type
- Biologics
View Company Profile
ID · 0ebf4560-13f1-4fd8-be81-d39157ab326f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1171593
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.65(b)(2)Labeled re: biohazard, risks, test results
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 2, 2021 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| January 22, 2020 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc.
- FDA Inspection 1147861 - 2021-08-02
- FDA Inspection 1116246 - 2020-01-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.